Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
Frontiers in Immunology
|
September 6, 2024
COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis
Susana Sainz de la Maza, Alexander Rodero-Romero, Enric Monreal, et al.
Annals of Clinical and Translational Neurology
|
March 9, 2019
Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients
Silvia Medina, Susana Sainz de la Maza, Noelia Villarrubia, et al.
Neuropsychiatric Disease and Treatment
|
August 5, 2025
Neurologists' Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants
Enric Monreal, Rocío Gómez-Ballesteros, Virginia Meca-Lallana, et al.
Frontiers in Immunology
|
November 13, 2023
Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis
Enric Monreal, José Ignacio Fernández-Velasco, Ana García-Soidán, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
December 15, 2025
How do neurologists perceive the organization and functioning of multiple sclerosis care units?
Lamberto Landete, Rocío Gómez-Ballesteros, Virginia Meca-Lallana, et al.
Vaccines
|
September 28, 2023
Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine
Alexander Rodero-Romero, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, et al.
Frontiers in Immunology
|
September 3, 2024
Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis
Raquel Sainz-Amo, Alexander Rodero Romero, Enric Monreal, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 24, 2021
Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome
Enric Monreal, Susana Sainz de la Maza, Lucienne Costa-Frossard, et al.
International Journal of Molecular Sciences
|
December 17, 2024
Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients
Raquel Sainz-Amo, Alexander Rodero-Romero, Enric Monreal, et al.
Scientific Reports
|
April 30, 2021
Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment
Paulette Esperanza Walo-Delgado, Susana Sainz de la Maza, Noelia Villarrubia, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
Frontiers in Immunology
|
September 6, 2024
COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis
Susana Sainz de la Maza, Alexander Rodero-Romero, Enric Monreal, et al.
Annals of Clinical and Translational Neurology
|
March 9, 2019
Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients
Silvia Medina, Susana Sainz de la Maza, Noelia Villarrubia, et al.
Neuropsychiatric Disease and Treatment
|
August 5, 2025
Neurologists' Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants
Enric Monreal, Rocío Gómez-Ballesteros, Virginia Meca-Lallana, et al.
Frontiers in Immunology
|
November 13, 2023
Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis
Enric Monreal, José Ignacio Fernández-Velasco, Ana García-Soidán, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
December 15, 2025
How do neurologists perceive the organization and functioning of multiple sclerosis care units?
Lamberto Landete, Rocío Gómez-Ballesteros, Virginia Meca-Lallana, et al.
Vaccines
|
September 28, 2023
Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine
Alexander Rodero-Romero, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, et al.
Frontiers in Immunology
|
September 3, 2024
Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis
Raquel Sainz-Amo, Alexander Rodero Romero, Enric Monreal, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 24, 2021
Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome
Enric Monreal, Susana Sainz de la Maza, Lucienne Costa-Frossard, et al.
International Journal of Molecular Sciences
|
December 17, 2024
Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients
Raquel Sainz-Amo, Alexander Rodero-Romero, Enric Monreal, et al.
Scientific Reports
|
April 30, 2021
Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment
Paulette Esperanza Walo-Delgado, Susana Sainz de la Maza, Noelia Villarrubia, et al.
Page
of 6